|
Theseus Pharmaceuticals Inc (NASDAQ: THRX) |
|
Theseus Pharmaceuticals Inc
THRX's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Theseus Pharmaceuticals Inc 's sales fell
in III. Quarter 2023 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -4.76 %
Theseus Pharmaceuticals Inc net loss decreased from $-15 millions, to $-14 millions in III. Quarter 2023,
• More on THRX's Growth
|
|
Theseus Pharmaceuticals Inc realized a net loss in trailing twelve months.
Theseus Pharmaceuticals Inc realized cash reduction of $ -4.51 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.
• More on THRX's Valuation
|
|
|
|
|
Theseus Pharmaceuticals Inc realized net loss in trailing twelve months.
Theseus Pharmaceuticals Inc realized cash outflow of $ -4.51per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.
Theseus Pharmaceuticals Inc Price to Book Ratio is at 0.79 lower than Industry Avg. of 90.03. and higher than S&P 500 Avg. of 0.01
• More on THRX's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com